4//SEC Filing
Lim Bryant David 4
Accession 0001179110-21-000525
CIK 0000861838other
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 8:15 PM ET
Size
5.8 KB
Accession
0001179110-21-000525
Insider Transaction Report
Form 4
Lim Bryant David
SVP & General Counsel
Transactions
- Sale
Common Stock
2021-01-05$3.91/sh−1,465$5,722→ 39,775 total
Footnotes (3)
- [F1]Represents the number of shares of Issuer common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 4,525 Restricted Stock Units ("RSUs") on January 3, 2021. This sale is mandated by the Issuer's election under its 2013 Stock Incentive Plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
- [F2]The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $3.90 to $3.945 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Of the reported securities beneficially owned, 29,050 shares are represented by unvested RSUs.
Documents
Issuer
IDERA PHARMACEUTICALS, INC.
CIK 0000861838
Entity typeother
Related Parties
1- filerCIK 0001752888
Filing Metadata
- Form type
- 4
- Filed
- Jan 10, 7:00 PM ET
- Accepted
- Jan 11, 8:15 PM ET
- Size
- 5.8 KB